Skip to content
SSDP/Country guide

🇳🇴 Norway

Norway: youth-friendly drug policy guide.

EuropeNo chapter yetHRI 2024 country data

Legal context

European countries vary widely, from decriminalisation and diversion models to criminal penalties, with growing debate on cannabis regulation and health-led responses.

Health response (HRI 2024)

Harm Reduction International (2024) reports at least one operational service in Norway: needle & syringe programmes, opioid agonist therapy, drug consumption rooms, take-home naloxone. Inside prisons: OAT. National policy documents include an explicit supportive reference to harm reduction.

Youth leadership

Youth participation often happens through civil-society coalitions, student movements, municipal consultations and European-level advocacy networks.

This country page gives a plain-language starting point for understanding drug policy in Norway. Harm reduction data is drawn from Harm Reduction International's Global State of Harm Reduction 2024 where available; detailed national law should always be checked against current local sources.

Drug policy briefing

What young people should know about drug policy in Norway

Decriminalisation

Diverse legal models

Some countries use administrative responses or diversion for personal possession, while others retain criminal penalties. Cannabis regulation is advancing unevenly.

Evidence · Regional baseline: EMCDDA/EUDA country legal profiles.

Harm Reduction

Broad service coverage

Harm Reduction International (2024) reports at least one operational service in Norway: needle & syringe programmes, opioid agonist therapy, drug consumption rooms, take-home naloxone. Inside prisons: OAT. National policy documents include an explicit supportive reference to harm reduction.

Evidence · Harm Reduction International, Global State of Harm Reduction 2024 (Table 1), hri.global.

Youth Participation

Consultative spaces

Youth and civil society can access some consultation processes, but meaningful co-design with young people who use drugs remains uneven.

Evidence · Regional baseline: Council of Europe, EU and civil-society consultations.

Treatment Systems

Integrated, access varies

Treatment is often linked to public health systems, with stronger coverage in some countries than others and persistent gaps for young people.

Evidence · Regional baseline: WHO Europe and EMCDDA/EUDA materials.

Sources · Harm Reduction International, Global State of Harm Reduction 2024 · UNODC · WHO · EMCDDA/EUDA · national laws and civil-society monitoring. Last reviewed Harm Reduction International 2024.